» Articles » PMID: 35676466

Vertebral Fractures at Hospitalization Predict Impaired Respiratory Function During Follow-up of COVID-19 Survivors

Overview
Journal Endocrine
Specialty Endocrinology
Date 2022 Jun 8
PMID 35676466
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Morphometric vertebral fractures (VFs) have been recently reported as an important component of the endocrine phenotype of COVID-19 and emerging data show negative respiratory sequelae at long-term follow-up in COVID-19 survivors. The aim of this study was to evaluate the impact of VFs on respiratory function in COVID-19 survivors.

Methods: We included patients referred to our Hospital Emergency Department and re-evaluated during follow-up. VFs were detected on lateral chest X-rays on admission using a qualitative and semiquantitative assessment and pulmonary function tests were obtained by Jaeger-MasterScreen-Analyzer Unit 6 months after discharge.

Results: Fifty patients were included. Median age was 66 years and 66% were males. No respiratory function data were available at COVID-19 diagnosis. VFs were detected in 16 (32%) patients. No differences between fractured and non-fractured patients regarding age and sex were observed. Although no difference was observed between VF and non-VF patient groups in the severity of pneumonia as assessed by Radiological-Assessment-of-Lung-Edema score at admission, (5 vs. 6, p = 0.69), patients with VFs were characterized as compared to those without VFs by lower Forced Vital Capacity (FVC, 2.9 vs. 3.6 L, p = 0.006; 85% vs. 110% of predicted, respectively, p = 0.001), Forced Expiratory Volume 1st s (FEV1, 2.2 vs. 2.8 L, p = 0.005; 92% vs. 110% of predicted, respectively, p = 0.001) and Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO 5.83 vs. 6.98 mmol/min/kPa, p = 0.036, 59% vs. 86.3% of predicted, respectively, p = 0.043) at 6-month follow up.

Conclusions: VFs, expression of the endocrine phenotype of the disease, appear to influence medium-term impaired respiratory function of COVID-19 survivors which may significantly influence their recovery. Therefore, our findings suggest that a VFs assessment at baseline may help in identifying patients needing a more intensive respiratory follow-up and patients showing persistent respiratory impairment without evidence of pulmonary disease may benefit from VFs assessment to preventing the vicious circle of further fractures and respiratory deterioration.

Citing Articles

Morphometric vertebral fractures at hospitalization associate with Long COVID occurrence.

Di Filippo L, Doga M, Mangini F, Gifuni L, Sahagun S, Querini P J Endocrinol Invest. 2025; .

PMID: 39932650 DOI: 10.1007/s40618-025-02544-1.


Bone Mineral Density, Bone Biomarkers, and Joints in Acute, Post, and Long COVID-19: A Systematic Review.

Alghamdi F, Mokbel K, Meertens R, Obotiba A, Alharbi M, Knapp K Viruses. 2024; 16(11).

PMID: 39599809 PMC: 11599111. DOI: 10.3390/v16111694.


TSH-secreting pituitary adenomas and bone.

Losa M, Vassallo A, Frara S, Mortini P, Giustina A Pituitary. 2024; 27(6):752-760.

PMID: 39476262 DOI: 10.1007/s11102-024-01467-z.


Clinical outcomes of COVID-19 infection in patients with osteoporosis: a nationwide cohort study in Korea using the common data model.

Ahn S, Seo S, Jung C, Yu D, Kim Y, Cho Y Sci Rep. 2024; 14(1):17738.

PMID: 39085367 PMC: 11291711. DOI: 10.1038/s41598-024-68356-0.


COVID-19 and Bone Loss: A Review of Risk Factors, Mechanisms, and Future Directions.

Creecy A, Awosanya O, Harris A, Qiao X, Ozanne M, Toepp A Curr Osteoporos Rep. 2024; 22(1):122-134.

PMID: 38221578 PMC: 10912142. DOI: 10.1007/s11914-023-00842-2.


References
1.
Di Filippo L, Formenti A, Doga M, Pedone E, Rovere-Querini P, Giustina A . Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes. J Clin Endocrinol Metab. 2020; 106(2):e602-e614. PMC: 7797741. DOI: 10.1210/clinem/dgaa738. View

2.
Puig-Domingo M, Marazuela M, Giustina A . COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine. 2020; 68(1):2-5. PMC: 7150529. DOI: 10.1007/s12020-020-02294-5. View

3.
Marazuela M, Giustina A, Puig-Domingo M . Endocrine and metabolic aspects of the COVID-19 pandemic. Rev Endocr Metab Disord. 2020; 21(4):495-507. PMC: 7343578. DOI: 10.1007/s11154-020-09569-2. View

4.
Giustina A . Hypovitaminosis D and the endocrine phenotype of COVID-19. Endocrine. 2021; 72(1):1-11. PMC: 7972333. DOI: 10.1007/s12020-021-02671-8. View

5.
Giustina A, Marazuela M, Reincke M, Yildiz B, Puig-Domingo M . One year of the pandemic - how European endocrinologists responded to the crisis: a statement from the European Society of Endocrinology. Eur J Endocrinol. 2021; 185(2):C1-C7. PMC: 9494341. DOI: 10.1530/EJE-21-0397. View